The eye-care company Alcon Research has entered into licensing and purchase option agreements with Potentia Pharmaceuticals to develop Potentia's leading drug candidate — a complement pathway ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

Mannan-binding lectin (MBL), M-, L- and H-ficolin recognize microorganisms and activate the complement system via MBL-associated serine proteases (MASPs). We investigated lectin pathway cord blood ...

Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant ...

Annexon Biosciences (ANNX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew ...

And new insights from the current analysis found significant changes from baseline in complement pathway biomarkers. In the iptacopan arm, urinary sC5b-9 levels -- a marker of complement ...

The complement system, a pivotal element of antiviral immunity, is a cascade of proteins found in the bloodstream and at mucosal sites, such as the respiratory tract. Activated through three different ...

MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ...

A new study has developed an innovative approach to combat antibiotic-resistant bacteria by tagging them with a chimeric agent that activates the immune system towards them.